Burden and trends of breast cancer worldwide: Opportunities for prevention?

Understanding Ghana's FDA and pharmacovigilance regulations

Understanding Zimbabwe's pharmacovigilance system

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer

Disparities in mammogram screening amongst LGBTQ+ populations

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Social determinants and survival outcomes in early-onset colorectal cancer in the US

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform

ASCO 2025: Update on blood-based cancer assays

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab

CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise